MDM4 and leukemia: These results strongly imply that E/R specifically attenuates the p53 pathway through upregulation of MDM2. Of note, none of the various leukemia expression profiles provided any evidence for a similar participation of MDMX, which is the second major negative regulator of p53,13 in E/R-positive cases.